Bharat Biotech is expected to initiate Phase-1 trials of its intranasal vaccine for Covid-19 next month, chairman and MD Krishna Ella said on Tuesday. He said his firm is setting up two more facilities for manufacturing vaccines, including for Covaxin.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3lXY6hr
0 Comments